Home/Filings/4/0001179110-19-010487
4//SEC Filing

Heberlig Chris 4

Accession 0001179110-19-010487

CIK 0001730430other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 4:16 PM ET

Size

5.4 KB

Accession

0001179110-19-010487

Insider Transaction Report

Form 4
Period: 2019-09-17
Heberlig Chris
Exec VP & CFO10% Owner
Transactions
  • Award

    Share Option

    2019-09-17+50,00050,000 total
    Exercise: $8.83Exp: 2029-09-16Class A Common Shares (50,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is September 17, 2019.

Issuer

Kiniksa Pharmaceuticals, Ltd.

CIK 0001730430

Entity typeother

Related Parties

1
  • filerCIK 0001532217

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:16 PM ET
Size
5.4 KB